Clinical Trial Update: This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma. [Phase 1, Phase 2]

View source ↗

Summary

An early Phase 1/2 clinical trial evaluating the drug Gimatecan in adults with malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• gimatecan (gimatecan)

Snippet

Sponsor: Sigma-Tau Research, Inc. | Conditions: Malignant Glioma | Phase 1, Phase 2 | Status: COMPLETED